ASAlba Sánchez-Galán

Alba Sánchez-Galán

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Alba Sánchez-Galán has a total of 49 co-authors. Here are the top co-authors by number of shared publications:

  • Ane Miren Andrés

    Congenital Malformations and Transplantation Research Group, Hospital La Paz Institute for Health Research (IdiPAZ), Madrid, Spain; Department of Pediatric Surgery, La Paz University Hospital (Hospital Universitario La Paz, HULP), Madrid, Spain

    4 shared publications
  • Esther Ramos Boluda

    Pediatric Gastroenterology Intestinal Rehabilitation Unit La Paz University Hospital Madrid Spain

    4 shared publications
  • Francisco Hernández

    Pediatric Surgery Department, Hospital Universitario La Paz, 28046 Madrid, Spain

    3 shared publications
  • Javier Serradilla

    Congenital Malformations and Transplantation Research Group, Hospital La Paz Institute for Health Research (IdiPAZ), Madrid, Spain; Department of Pediatric Surgery, La Paz University Hospital (Hospital Universitario La Paz, HULP), Madrid, Spain

    3 shared publications
  • Pablo Stringa

    Congenital Malformations and Transplantation Research Group, Hospital La Paz Institute for Health Research (IdiPAZ), Madrid, Spain; Institute for Immunological and Pathophysiological Studies (IIFP), School of Exact Sciences, National University of La Plata, National Council of Scientific and Technical Research (CONICET), La Plata, Argentina; Organ Transplant Laboratory, School of Medicine, National University of La Plata, La Plata, Argentina

    3 shared publications
  • Paloma Talayero

    Department of Immunology, University Hospital 12 de Octubre, Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), Madrid, Spain

    3 shared publications

Latest Publications

  • Open Access

    63: DCD in intestinal transplantation: the path to prove its validity in both experimental and clinical models

    by Javier Serradilla, Ane Miren Andrés Moreno, Paula Burgos, Paloma Talayero, Jose Luis Encinas, Alba Sánchez Galán, Carlos Andrés De la Torre Ramos, Alida Alcolea, Rocío González Sacristán, Pilar Serrano, et al.

  • Open Access

    First case report of multivisceral transplant from a deceased cardiac death donor

    by Ane M. Andres, Jose Luis Encinas, Alba Sánchez-Galán, Javier Serradilla Rodríguez, Karla Estefania, Rocio Gonzalez Sacristan, Alida Alcolea, Pilar Serrano, Belén Estébanez, Iñigo Velasco Leon, et al.


  • Delayed introduction of sirolimus in paediatric intestinal transplant recipients: indications and long‐term benefits

    by Ane M. Andres, Paloma Talayero, Alida Alcolea Sanchez, Alba Sanchez Galán, Javier Serradilla Rodríguez, Alba Bueno Jimenez, Rocío Gonzalez Sacristan, Pablo Stringa, Rodrigo Papa Gobbi, Maria Lasa Lazaro, et al.

    Aim To review our experience using sirolimus in a single center pediatric intestinal transplantation cohort. Patient/Methods Intestinal transplant patients with more than 3 months follow-up were divided in two groups according to their immunosuppression regimen: tacrolimus, (TAC group, n=45 grafts) or sirolimus (SRL group, n=38 grafts), which included those partially or completely converted from tacrolimus to sirolimus. The indications to switch were tacrolimus side-effects and immunological complications. Survival and complications were retrospectively analyzed comparing both groups. Results SRL was introduced 9 months (0 months-16.9 years) after transplant. The main cause for conversion was worsening renal function (45%), followed by hemolytic anemia (21%) and graft-versus-host-disease (16%). Both groups showed a similar overall patient/graft survival (p=0.76/0.08) and occurrence of rejection (24%/17%, p=0.36). Immunological complications did not recur after conversion. Renal function significantly improved in most SRL patients. After a median follow-up of 65.17 months, 28/46 survivors were on SRL, 26 with monotherapy, with good graft function. Conclusions Over one-third of our patients eventually required SRL conversion that allowed to improve their kidney function and immunological events, without entailing additional complications or survival impairment. Further trials are warranted to clarify the potential improvement of the standard tacrolimus maintenance by sirolimus conversion or addition.


  • Open Access

    New mutations associated with Hirschsprung disease

    by Marta Lorente-Ros, Ane Miren Andrés, Alba Sánchez-Galán, Cinthia Amiñoso, Sixto García, Pablo Lapunzina, Jesús Solera-García


  • Open Access

    Nuevas mutaciones asociadas a la enfermedad de Hirschsprung

    by Marta Lorente-Ros, Ane Miren Andrés, Alba Sánchez-Galán, Cinthia Amiñoso, Sixto García, Pablo Lapunzina, Jesús Solera García


  • Surgical Rehabilitation Techniques in Children with Poor Prognosis Short Bowel Syndrome

    by Paloma Triana Junco, Ane M. Andres, Alba Sánchez-Galán, Maria Virginia Amesty, Esther Ramos, Gerardo Prieto, Francisco Hernandez, Manuel Lopez Santamaria, Mariela Dore

    Intestinal failure (IF) requires a multidisciplinary management based on nutritional support, surgical and medical rehabilitation, and transplantation. The aim of this study is to review our experience with surgical rehabilitation techniques (SRTs: enteroplasty, Bianchi, Serial Transverse Enteroplasty Procedure [STEP]) in patients with short bowel syndrome (SBS) and poor prognosis due to complex abdominal pathology. We performed a single-center retrospective study of patients with IF evaluated for intestinal transplantation in the Intestinal Rehabilitation Unit who underwent an SRT. Nonparametric tests were used for statistical analysis. A total of 205 patients (107 males/98 females) with mean age of 25 ± 7 months were assessed for IF. A total of 433 laparotomies were performed on 130 patients including intestinal resection, enteroplasties, adhesiolysis, and transit reconstruction. SRT were performed in 22 patients: 12 enteroplasties, 8 STEPs, and 4 Bianchi procedures. All patients were parenteral nutrition (PN) dependent with different stages of liver disease: mild (13), moderate (5), and severe (4). The adaptation rate for patients who underwent enteroplasty, STEP, and Bianchi were 70, 63, and 25%, respectively, although the techniques are not comparable. Overall, intestinal adaptation was achieved in nine (41%) patients, and four (18%) patients showed significant reduction of PN needs. One child did not respond to SRT and did not meet transplantation criteria. The remaining eight (36%) patients were included on the waiting list for transplant: four were transplanted, two are still on the waiting list, and two died. Better outcomes were observed in milder cases of liver disease (mild 77%, moderate 40%, severe 25%) (p < 0.05). Conversely, a trend toward a poorer outcome was observed in cases with ultrashort bowel (p > 0.05). One patient required reoperation after a Bianchi procedure due to intestinal ischemia and six needed further re-STEP or adhesiolysis procedure several months later. The median follow-up was 62 (3–135) months. Overall mortality was 19%, and was due to end-stage liver disease and/or central venous catheter–related sepsis. SRT led to intestinal adaptation in a significant number of patients with poor prognosis SBS referred for intestinal transplantation. However, SRT requires a multidisciplinary evaluation and should be attempted only in suitable cases. Careful assessment and optimal surgical timing is crucial to obtain a favorable outcome.


  • Comparative fluorescein angiography of the normal sheep and goat ocular fundi

    by Alba Galán, Eva M. Martín‐Suárez, M. Mar Granados, José M. Gallardo, José M. Molleda

    Fluorescein angiography without sedative or anesthetic agents was evaluated in 20 normal goats and 20 normal sheep. All of the angiographic phases were observed using 20 mg/kg fluorescein IV in both species. Fundus fluorescein angiography results revealed wide stars of Winslow in the tapetal fundus, central or marginal flow during the first part of the arterial phase, delayed filling of the focal areas in the choroid near the optic disc that often coincided with others in the disc, and lack of evidence of the 'striate area' in the tapetal fundi. In goats, the angiographic times were 6.54+/-1.25 s for the arterial phase (TA), 7.80+/-1.37 s for the arterio-venous phase (TAV), and 14.13+/-2.01 s for the venous phase (TV). I1: 1.30+/-0.30 s (time elapsing between TA and TAV), and I2: 6.20+/-1.60 s (time elapsing between TAV and TV). In sheep, times were 9.54+/-2.18 s TA, 11.73+/-2.10 s TAV, and 20.86+/-2.74 s TV. I1: 2.04+/-0.75 s and I2: 8.98+/-2.47 s, respectively. Due to the large size of the fundic vessels in sheep and goats, fluorescein angiography of the retinal vasculature can facilitate the study of the different vascular diseases in these species.